North America Generic Injectables Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Generic Injectables Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Generic Injectables Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Generic Injectables Market Regional Analysis

6.2 North America Generic Injectables Market Revenue 2019-2028 (US$ Million)

6.3 North America Generic Injectables Market Forecast Analysis

7. North America Generic Injectables Market Analysis – by Product Type

7.1 Large Molecule Injectables

7.1.1 Overview
7.1.2 Large Molecule Injectables: North America Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Small Molecule Injectables

7.2.1 Overview
7.2.2 Small Molecule Injectables: North America Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Generic Injectables Market Analysis – by Container Type

8.1 Vials

8.1.1 Overview
8.1.2 Vials: North America Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Premix

8.2.1 Overview
8.2.2 Premix: North America Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Prefilled Syringes

8.3.1 Overview
8.3.2 Prefilled Syringes: North America Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.4 Ampoules

8.4.1 Overview
8.4.2 Ampoules: North America Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Generic Injectables Market Analysis – by Application

9.1 Oncology

9.1.1 Overview
9.1.2 Oncology: North America Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Infectious Diseases

9.2.1 Overview
9.2.2 Infectious Diseases: North America Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Cardiology

9.3.1 Overview
9.3.2 Cardiology: North America Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.4 Diabetes

9.4.1 Overview
9.4.2 Diabetes: North America Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.5 Immunology

9.5.1 Overview
9.5.2 Immunology: North America Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America Generic Injectables Market Analysis – by Route of Administration

10.1 Intravenous

10.1.1 Overview
10.1.2 Intravenous: North America Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.2 Intramuscular

10.2.1 Overview
10.2.2 Intramuscular: North America Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.3 Subcutaneous

10.3.1 Overview
10.3.2 Subcutaneous: North America Generic Injectables Market – Revenue and Forecast, 2019-2028 (US$ Million)

11. North America Generic Injectables Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Generic Injectables Market Breakdown, by Key Country, 2022 and 2028 (%)
11.2.1.1 North America Generic Injectables Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 US: North America Generic Injectables Market Breakdown, by Product Type
11.2.1.1.2 US: North America Generic Injectables Market Breakdown, by Container Type
11.2.1.1.3 US: North America Generic Injectables Market Breakdown, by Application
11.2.1.1.4 US: North America Generic Injectables Market Breakdown, by Route of Administration

11.2.1.2 Canada: North America Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Canada: North America Generic Injectables Market Breakdown, by Product Type
11.2.1.2.2 Canada: North America Generic Injectables Market Breakdown, by Container Type
11.2.1.2.3 Canada: North America Generic Injectables Market Breakdown, by Application
11.2.1.2.4 Canada: North America Generic Injectables Market Breakdown, by Route of Administration

11.2.1.3 Mexico : North America Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 Mexico : North America Generic Injectables Market Breakdown, by Product Type
11.2.1.3.2 Mexico : North America Generic Injectables Market Breakdown, by Container Type
11.2.1.3.3 Mexico : North America Generic Injectables Market Breakdown, by Application
11.2.1.3.4 Mexico : North America Generic Injectables Market Breakdown, by Route of Administration

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 AstraZeneca

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Baxter International Inc.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Biocon

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Fresenius SE & Co. KGaA

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 GlaxoSmithKline plc

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Hikma Pharmaceuticals PLC

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Johnson and Johnson Services, Inc.

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Lupin

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Merck & Co., Inc.

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Pfizer Inc.

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

14.11 Viatris Inc

14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Generic Injectables Market